3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
37
fludarabine phosphate
31
Busulfan
25
Antilymphocyte Serum
22
Mycophenolic Acid
20
Melphalan
19
Cyclosporine
19
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Cord Blood Stem Cell Transplantation
16
Whole-Body Irradiation
14
Tacrolimus
14
Radiotherapy
14
Methylprednisolone
13
fludarabine
11
Methotrexate
8
Epoetin Alfa
8
Etoposide
7
Cytarabine
7
Thiotepa
6
Alemtuzumab
6
thymoglobulin
4
Granulocyte Colony-Stimulating Factor
4
Darbepoetin alfa
3
Bone Marrow Transplantation
3
Stem Cell Transplantation
2
Sirolimus
2
Rituximab
2
Mesna
2
Influenza Vaccines
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
enoxaparin sodium
×
Classical hematology
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled